Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mangoceuticals, Inc.

1.48
+0.290024.37%
Pre-market: 1.43-0.0500-3.38%06:38 EST
Volume:3.82M
Turnover:4.85M
Market Cap:20.58M
PE:-0.47
High:1.49
Open:1.13
Low:1.13
Close:1.19
52wk High:6.15
52wk Low:0.9800
Shares:13.91M
Float Shares:7.55M
Volume Ratio:0.27
T/O Rate:50.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1399
EPS(LYR):-4.8401
ROE:-85.90%
ROA:-43.25%
PB:1.07
PE(LYR):-0.31

Loading ...

Company Profile

Company Name:
Mangoceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
3
Office Location:
15110 N. Dallas Parkway,Suite 600,Dallas,Texas,United States
Zip Code:
75248
Fax:
- -
Introduction:
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Directors

Name
Position
Jacob D. Cohen
Director,Chairman and Chief Executive Officer
Alex P. Hamilton
Director
Kenny Myers
Director
Lorraine D'Alessio
Director

Shareholders

Name
Position
Jacob D. Cohen
Director,Chairman and Chief Executive Officer
Eugene M. Johnston
Chief Financial Officer